Showing results (31-40 of 212) with videos related to
Sort By:
Pageof 22
Alimentary Pharmacology & Therapeutics|January 19, 2007
Systematic review: Infliximab therapy in ulcerative colitisJ P Gisbert, Y González-Lama, J MatéAlimentary Pharmacology & Therapeutics|March 12, 2014
Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitisC Castaño-Milla, M Chaparro, J P GisbertHepato-Gastroenterology|October 27, 2001
Are twelve days of omeprazole, amoxicillin and clarithromycin better than six days for treating H. pylori infection in peptic ulcer and in non-ulcer dyspepsia?J P Gisbert, C Hermida, J M PajaresRevista Clinica Espanola|December 9, 2000
[Effect of Helicobacter pylori eradication on histological lesions of gastric mucosa. An 18-month follow-up study]J P Gisbert, M Blanco, J M PajaresEuropean Journal of Clinical Investigation|January 30, 2008
Angiogenesis in inflammatory bowel diseaseI D Pousa, J Maté, J P GisbertAlimentary Pharmacology & Therapeutics|June 16, 2015
Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti-TNF therapyJ P Gisbert, A C Marín, M ChaparroMucosal Immunology|May 11, 2018
Human intestinal pro-inflammatory CD11chighCCR2+CX3CR1+ macrophages, but not their tolerogenic CD11c-CCR2-CX3CR1- counterparts, are expanded in inflammatory bowel diseaseD Bernardo, A C Marin, S Fernández-Tomé, et al.Alimentary Pharmacology & Therapeutics|September 13, 2003
Meta-analysis: comparative efficacy of different proton-pump inhibitors in triple therapy for Helicobacter pylori eradicationM Vergara, M Vallve, J P Gisbert, et al.Atencion Primaria|March 9, 2011
[Use of health resources and loss of productivity in gastroesophageal reflux disease: results of a cross-sectional study in a primary care setting in Spain]Javier Nuevo, Mónica Tafalla, Javier Zapardiel, et al.Anales De Medicina Interna (Madrid, Spain : 1984)|February 1, 1995
[Gastrointestinal lesions produced by nonsteroidal anti-inflammatory agents: the clinical manifestations, risk factors, physiopathology, prevention and treatment]C Martín de Argila, V Moreira, J P GisbertPageof 22